Jacopo Chiaro

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC.

Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC.

Journal: Molecular therapy. Oncology

Published: October 29, 2025

Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.

Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: October 10, 2025

Single-cell spatial atlas of high-grade serous ovarian cancer uncovers MHC class II as a key predictor of spatial tumor ecosystems and clinical outcomes.

Single-cell spatial atlas of high-grade serous ovarian cancer uncovers MHC class II as a key predictor of spatial tumor ecosystems and clinical outcomes.

Journal: Cancer discovery

Published: August 27, 2025

Single-Cell Spatial Atlas of High-Grade Serous Ovarian Cancer Uncovers MHC Class II as a Key Predictor of Spatial Tumor Ecosystems and Clinical Outcomes.

Single-Cell Spatial Atlas of High-Grade Serous Ovarian Cancer Uncovers MHC Class II as a Key Predictor of Spatial Tumor Ecosystems and Clinical Outcomes.

Journal: Cancer discovery

Published: August 27, 2025

Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response.

Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response.

Journal: Nature communications

Published: April 16, 2025

Proteogenomic approach to immunopeptidomics of ovarian tumors identifies shared peptide vaccine candidates.

Proteogenomic approach to immunopeptidomics of ovarian tumors identifies shared peptide vaccine candidates.

Journal: NPJ vaccines

Published: March 06, 2025

Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.

Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.

Journal: Oncoimmunology

Published: October 01, 2024

Cancer vaccines: an update on recent achievements and prospects for cancer therapy.

Cancer vaccines: an update on recent achievements and prospects for cancer therapy.

Journal: Clinical and experimental medicine

Published: August 26, 2024

An automated and high-throughput approach for enhanced precision of adenoviral titering.

An automated and high-throughput approach for enhanced precision of adenoviral titering.

Journal: Molecular therapy. Methods & clinical development

Published: August 08, 2024

Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer.

Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer.

Journal: Advanced healthcare materials

Published: April 25, 2024

Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.

Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.

Journal: Journal for immunotherapy of cancer

Published: February 18, 2024

PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines.

PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines.

Journal: International journal of biological macromolecules

Published: August 01, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026